Subscribe to our email newsletter to get MSK’s latest information on cancer care and research. No one should go through prostate cancer alone. At MSK, our team of prostate cancer experts is here for ...

Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...

New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers why some leukemia patients stop responding to promising new drugs; examines how bone’s hardness shapes th ...

This resource explains steroid-induced hyperglycemia and the signs and symptoms to watch for. It also explains when to check for hyperglycemia, and tips to help manage blood glucose (blood sugar).

For people living with advanced triple-negative breast cancer (TNBC), a newly approved treatment may offer more time and a better quality of life. TNBC makes up about 10% to 20% of all breast cancers, ...

Memorial Sloan Kettering Cancer Center today announced that Shakeeb Akhter has joined MSK as its new Chief Digital Officer.

MSK gastrointestinal medical oncologist Dr. Wungki Park led the early phase clinical trial of daraxonrasib for people with metastatic pancreatic cancer that had stopped responding to chemotherapy.

MSK's Dr. Caleb Lareau was awarded a 2026 Pershing Square Sohn Cancer Prize, which is designed to empower early-career investigators to pursue bold, high-impact projects.

MSK gastrointestinal medical oncologist Eileen O'Reilly, MD (left), led a very promising early phase clinical trial of the targeted RAS therapy daraxonrasib for people facing pancreatic cancer, ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, MSK ...

How Does Acupuncture Help Breast Cancer Survivors? The trial found that patients in the real and sham acupuncture groups had clinically meaningful improvements in how they perceived their cognitive ...

Research at MSK Our research impact Research topics Core facilities & resources ...